IN SUMMARY: Peccisism; a tendency to see the worst aspect of things or believe that the worst will happen; a lack of hope or confidence in the future. When it comes to pharma that pretty much describes me. In my 20+ years in healthcare marketing, I have seen a transformation from an industry focused on patients to an industry focused on profits.
Continue reading
There are millions of people around the world who are living better lives because of the drugs that the pharmaceutical industry develops, but that doesn’t mean that the industry can continue to put Wall Street over patients.
Continue reading
The pharma industry has been good to me and my wife. It has provided a good living and allowed me to grow professionally and personally. Yet, as an Editor for PM360 and working on a consulting team I have been challenged to either remain quiet when I see clients, focusing too much on things that aren’t important to patients versus listening to our audience at a time when a lot of people are going to need good healthcare. Continue reading
POST SUMMARY: My post last week on the Actos judgement generated quite a lot of debate over at LinkedIn. While most agreed with my take on the judgement there were of course the people who believe that it’s just pharma’s way of doing business. I can understand that perception with current litigation against brands like Pradaxa who seem to have put sales ahead of clinical trial transparency but there are a lot of very good, hard working people, within the industry and only when their voices are heard louder than those who look at the balance sheet will we ensure patients are always put first. Continue reading